Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The Fed is Set to Cut Rates in September, Tariffs Have Limited Impact on CPI

The Fed is Set to Cut Rates in September, Tariffs Have Limited Impact on CPI

ChaincatcherChaincatcher2025/08/12 14:46
Show original

According to ChainCatcher, citing Jinshi News, Guy Lebas, Chief Fixed Income Strategist at Janney Montgomery Scott, stated that July’s CPI was largely in line with expectations, and tariffs have had a limited impact on consumer prices, which provides grounds for the Federal Reserve to consider a rate cut in September. Although there is still some time before the meeting, the current inflation data is not a cause for concern. Lebas noted that the effects of tariffs have not yet fully materialized, and future inflation may rise, or companies may be absorbing the impact of tariffs, thus preventing it from being passed on to consumer inflation.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11